When Should You Stop Mounjaro — and How Do You Know?

Step 1, Understand what the clinical threshold for stopping actually is

NICE's appraisal of tirzepatide sets out a straightforward benchmark: if you have not lost at least 5% of your starting body weight after six months on the highest dose your prescriber considers appropriate, continuing treatment should be reviewed. That is not an automatic stop, it is a clinical conversation. Your prescriber will look at whether the dose was genuinely optimised, whether there were practical barriers (illness, missed injections, significant life stressors), and whether the benefit-risk balance still makes sense for you specifically.

This threshold exists because Mounjaro is a resource-intensive treatment. Persisting indefinitely when the response is minimal exposes you to ongoing side effects and cost without the counterweight of meaningful benefit. The NICE appraisal of tirzepatide (TA1026) is the most authoritative UK source on this question, and it is worth reading the recommendations chapter directly if you want the exact wording. For a fuller picture of what Mounjaro involves from the start, the Mounjaro overview at nume covers the full clinical picture.

Step 2, Recognise the medical reasons that make stopping urgent or necessary

Some situations mean stopping sooner, not waiting for a six-month review. Pregnancy is one: Mounjaro is not recommended during pregnancy, breastfeeding, or when actively trying to conceive, so if any of those circumstances change, your prescriber needs to know immediately. Under-18s should not use it at all.

Pancreatitis is a more acute reason. In January 2026 the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, if uncommon, serious risk with GLP-1 medicines. Severe, persistent stomach pain that radiates to the back (with or without vomiting) needs urgent medical attention, and treatment should not continue until the cause is properly assessed. The same applies to serious allergic reactions or other significant adverse events your prescriber judges incompatible with carrying on.

Planned surgery is another trigger point. Anaesthetists need to know about tirzepatide because gastric-emptying effects can affect anaesthetic safety. NHS England advises telling your entire healthcare team, including your anaesthetist, well before any procedure. In practice, your surgical team will usually advise stopping for a defined period beforehand, your prescriber coordinates this. If you have questions about any of these situations, including the specific circumstances that make stopping Mounjaro the right call, the contact page connects you with our aftercare team seven days a week.

Step 3, Think about what happens after you stop, and why a plan matters

Weight regain after stopping GLP-1 medicines is well documented in the clinical literature. The biological mechanisms that Mounjaro modulates (appetite signalling, gastric emptying, satiety) do not simply stay changed once the medicine leaves your system. For most people, hunger gradually returns to something closer to its pre-treatment baseline over the weeks and months that follow. That is not a failure of willpower; it reflects how the medicine was working in the first place.

This is why stopping without a plan is different from stopping with one. A prescriber who knows you are stopping can help you think about what lifestyle adjustments are realistic, whether a maintenance approach or a future restart might be appropriate, and what to watch for. If you are weighing up whether Mounjaro is right for you at all before you start, our guide to help you decide whether to go on Mounjaro addresses that question directly. Understanding the cost of Mounjaro treatment over time is also a practical part of the stopping conversation, some people pause because of cost rather than clinical need, and that is worth discussing openly with your prescriber too.

The NHS medicines page on tirzepatide summarises the standard guidance on what to do if you miss doses or need to stop, and it is a sensible first reference alongside the Patient Information Leaflet in your pen box. At nume, every repeat order is reviewed by a real prescriber before it is approved, meaning every renewal is also an opportunity to reassess whether continuing is still the right decision for you, and a natural checkpoint if circumstances have changed. If you are not yet on treatment and want to understand the process, our advice on when you should take Mounjaro is a useful step before a consultation.